Healthcare Business News

J&J accepts $4 billion offer to sell Ortho-Clinical Diagnostics

By Beth Kutscher
Posted: March 31, 2014 - 3:00 pm ET

Johnson & Johnson, the pharmaceutical and medical-device giant, has accepted a $4 billion offer from the Carlyle Group to acquire its Ortho-Clinical Diagnostics business.

The New Brunswick, N.J.-based company disclosed plans to divest the unit in January; the divestiture is expected to close mid-year. J&J said it consulted with work councils and trade unions before accepting the private equity firm's offer.

Advertisement | View Media Kit


Ortho-Clinical Diagnostics makes products for clinical laboratories and blood banks. The company only breaks out earnings for three segments—consumer, pharmaceutical, and medical device and diagnostics—but said broadly on an earnings call that its diagnostics business declined 9.4% on an operational basis.

J&J began exploring options for the group last year to respond to competitive pressures, it said.

Follow Beth Kutscher on Twitter: @MHbkutscher

What do you think?

Share your opinion. Send a letter to the Editor or Post a comment below.

Post a comment

Loading Comments Loading comments...



Switch to the new Modern Healthcare Daily News app

For the best experience of on your iPad, switch to the new Modern Healthcare app — it's optimized for your device but there is no need to download.